Advances in drug discovery based on network pharmacology and omics technology
Authors:
- Yafeng LiuYLYafeng Liu
- Shujun ZhangSZShujun Zhang
- Kaijie LiuKLKaijie Liu
- Xinjun HuXHXinjun Hu
- Xinyu GuXGXinyu Gu
Top Cited Papers
Open Access
- 1 December 2024
- journal article
- Published by KEAI Publishing in Current Pharmaceutical Analysis
- Vol. 21 (1) , 33-43
Abstract
No abstract availableThis publication has 78 references indexed in Scilit:
- Exploring the mechanism underlying the therapeutic effects of butein in colorectal cancer using network pharmacology and single‐cell RNA sequencing dataThe Journal of Gene Medicine, 2023
- Enzyme-Linked Immunosorbent Assay: Types and Applications2023
- Recent advances in LC‐MS‐based metabolomics for clinical biomarker discoveryMass Spectrometry Reviews, 2022
- Integration of DNA Microarray with Clinical and Genomic Data2021
- Proteome Analysis with Classical 2D-PAGE2021
- Overview of multiplex immunohistochemistry/immunofluorescence techniques in the era of cancer immunotherapyCancer Communications, 2020
- Serum and urine metabolomics study reveals a distinct diagnostic model for cancer cachexiaJournal of Cachexia, Sarcopenia and Muscle, 2017
- The Strengths and Weaknesses of NMR Spectroscopy and Mass Spectrometry with Particular Focus on Metabolomics Research2015
- Overview of Mass Spectrometry-Based Metabolomics: Opportunities and Challenges2014
- Proteomics in biomarker discovery and drug developmentJournal of Cellular Biochemistry, 2003